StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Saturday morning. The brokerage issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Stock Down 8.4 %
NYSE BTX opened at $1.96 on Friday. Brooklyn ImmunoTherapeutics has a 52 week low of $0.17 and a 52 week high of $10.10. The company has a market cap of $115.30 million, a PE ratio of -0.86 and a beta of 4.61. The firm’s 50-day simple moving average is $2.15 and its two-hundred day simple moving average is $1.80.
Brooklyn ImmunoTherapeutics Company Profile
See Also
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Charles Schwab Fortifies its Uptrend on EPS Beat
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.